Entry_ID	SMILES	Target_RNA_sequence	Molecule_name	Molecule_ID	Target_RNA_name	Target_RNA_ID	pKd
1907	C1=CC=C(C=C1)C2=NN=C(O2)C3=NC4=CC=CC=C4C(=N3)NCCC5=CC=CS5	UGUGGGAGGGGCGGGUCUGGG	NRAS SAR 7	Target_lig_1057	NRAS G4 motif	Target_259	6.44369749923271
2501	O=C(Nc1ccc(cc1)C(=O)C)OC[C@H]1OC(=O)N[C@H]1CN1CCN(CC1)c1ccccc1	GAGGGUGGAACCGCGCUUCGGCGUCCCUC	Compound cis-2	Target_lig_1243	Antiterminator model RNA AM1A	Target_147	5.744727494896691
873	c12c(c(c3c(n1)cccc3)Nc1ccc(cc1)CNC(=O)[C@H](C(C)C)NC(=O)[C@H](NC(=O)CCCN)CO)cccc2C(=O)N[C@@H](C(=O)N)CCCNC(=N)N	GGGCGGUUUUUCGAAGCUUGAGUCUCUCGUAGAGGGCUUCGGCCUGGGCGCAAGACUGACGCUC	HTP 20	Target_lig_527	RNA aptamer_3	Target_58	6.11350927482752
2051	NCCCOc1ccc(cc1CNCCc1ccc(cc1)CNC(=N)N)c1cc2c(s1)cccc2	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	Rbt446	Target_lig_1126	HIV-1 TAR RNA	Target_19	6.65955588515988
1042	O1COc2c1cc(C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)NCCCN)CCCCN)CSSC[C@H](NC(=O)[C@@H]3CCCN3C(=O)c3cc4OCOc4cc3)C(=O)N[C@H](C(=O)NCCCN)CCCCN)CCC1)cc2	CCGCUGGGCAACCUGCGG	ligand 3-3	Target_lig_621	RNA seq C	Target_154	5.03151705144607
338	[C@H]1([C@H]([C@@H]([C@H](O[C@H]1CO)O[C@H]1[C@@H]([C@@H]([C@@H](C[C@H]1N)N)O)O[C@H]1OC[C@@H]([C@H]1OCCNCCc1ccccc1)O[C@@H]1[C@H]([C@@H](C[C@@H](O1)CN)O)N)N)O)O	GAGCGUCACACCUUCGGGUGAAGUCGCUC	Aminoglycoside derivative 15	Target_lig_264	Bacterial ribosomal A-site	Target_3	7.0
690	C1CNCCC1C2=NC3=CC(=C(C=C3N2CC4=CC=C(C=C4)Br)Cl)Cl	GAGCGUCACACCUUCGGGUGAAGUCGCUC	benzimidazole_analog_rRNA_33	Target_lig_449	16s_rRNA A SITE	Target_3	3.3625102704874905
1434	CCCN(C(=O)CNCc1nnn(c1)N=[N+]=Nn1nnc(c1)CO)CC(=O)N(CC(=O)N(CC(=O)N(CC(=O)N(CC(=O)N)CCC)CCC)CCC)CCC	GGGAGAGGGUUUAAUUCAUUCUACGAAAGUAGCGUUAAUUGGAUCCGCAAGG	Compound 1b	Target_lig_781	Pri-miR-515 and the adjacent RNA motif (RNA 4)	Target_271	4.69897000433602
948	c12cc(ccc1c(c1c(n2)ccc(c1)OC)NCCCCc1c(nc(nc1N)N)N)Cl	CUGGCUGCGCGCGCCGCCAG	MBNL CCUG ligand 3	Target_lig_563	RNA C	Target_145	3.7825160557860897
1050	O1COc2c1cc(C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)NCCCN)CCCCN)CSSC[C@H](NC(=O)[C@@H]3CCCN3C(=O)c3cc4OCOc4cc3)C(=O)N[C@H](C(=O)NCCCN)CCCCN)CCC1)cc2	CCAGCUGGCAACAGCUGG	ligand 3-3	Target_lig_621	RNA seq E	Target_156	4.67778070526608
1424	CN1CCN(CC1)C2=CC3=C(C=C2)N=C(N3)C4=CC5=C(C=C4)N=C(N5)C6=CC(=CC=C6)OCCCC(=O)NCCCN=[N+]=[N-]	AGCCCCUGCCCACCGCACACUGCGCUGCCCCAGACCCACUGUGCGUGUGACAGCGGCUGA	Targapremir-210-RL	Target_lig_1263	Pre-miR-210	Target_227	6.721246399047169
1766	OCC1OC(OC2C(N)CC(C(C2O)OC2OC(CNC(=O)c3ccc(c(c3)C(=O)O)c3c4ccc(=[N+](C)C)cc4oc4c3ccc(c4)N(C)C)C(CC2N)O)N)C(C(C1O)N)O	GGCUUAGUAUAGCGAGGUUUAGCUACACUCGUGCUGAGCC	Tobramycin-CRT	Target_lig_993	J6f1 RNA	Target_307	6.71534371721148
641	c1cccc(c1)c1ccc(cc1)CO[C@H](CO[C@@H]1O[C@@H]([C@H](O)[C@@H](O)[C@H]1N)CN)CN	GAGCGUCACACCUUCGGGUGAAGUCGCUC	Acyclic DOS mimic 1_biphenyl substituent	Target_lig_387	16s_rRNA A SITE	Target_3	5.6382721639824105
233	CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CC=C(O3)CN)N)N)N)O	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	sisomicin	Target_lig_10	HIV-1 TAR RNA	Target_19	6.1366771398795406
93	CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)CC(C(C(COP(=O)(O)OP(=O)(O)OCC4C(C(C(O4)N5C=NC6=C(N=CN=C65)N)O)O)O)O)O	GGCGUGUAGGAUAUGCUUCGGCAGAAGGACACGCC	FAD	Target_lig_67	35 nucleotide RNA	Target_26	4.6382721639824105
1253	CC1=NC2=C(C=C1)C(=C(S2)C(=O)NC3=CC=CC(=C3)C(F)(F)F)N	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	ST4133609	Target_lig_700	HIV-1 TAR	Target_19	5.619788758288389
929	OCc1ccc(cc1)CCc1ccc(cc1)CO[C@H]1[C@@H](C[C@H](N)[C@@H](O)[C@@H]1O)N	CGCGCAGUCAGUAGCGCG	DOS_der_4	Target_lig_549	RNA_XXII	Target_139	3.0
2430	CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CC=C(O3)CN)N)N)N)O	AUUUUUCCUCGAACUUAACGGAACGCAGAAAAAU	sisomicin	Target_lig_10	G17A,G18A SLI_mutant	Target_442	7.397940008672039
121	CC1=C(N=CC=C1)NCCN	GAGCGUCACACCUUCGGGUGAAGUCGCUC	methylpyridine_der_1	Target_lig_92	A-site 16S rRNA_E_coli (1)	Target_3	3.22184874961636
398	CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCOP(=O)(O)OP(=O)(O)[O-]	GGACUCGGGGUGCCCUUCUGCGUGAAGGCUGAGAAAUACCCGUAUCACCUGAUCUGGAUAAUGCCAGCGUAGGGAAGUUC	Thiamine_Pyrophosphate(TPP)	Target_lig_318	thiamine_BOX_Riboswitch	Target_72	6.221848749616361
246	C1CN(CCN1)CCNCC2=C(C=CC(=C2)C3=CC4=C(C=C3)NC=C4)OCCCN	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	Rbt550	Target_lig_187	HIV-1 TAR RNA	Target_19	7.30102999566398
1334	CCOc1ccc(cn1)NCC(Cn1c2ccc(cc2c2c1ccc(c2)Br)Br)O	GGGUUGACUGUUGAAUCUCAUGGCAACCC	Aniline_analog_5	Target_lig_729	miR-21 hairpin	Target_265	5.318758762624411
946	c12cc(ccc1c(c1c(n2)ccc(c1)OC)NCCCCc1c(nc(nc1N)N)N)Cl	GAGCGUCACACCUUCGGGUGAAGUCGCUC	MBNL CCUG ligand 3	Target_lig_563	RNA A	Target_3	3.52287874528034
1768	OCC1OC(OC2C(N)CC(C(C2O)OC2OC(CNC(=O)c3ccc(c(c3)C(=O)O)c3c4ccc(=[N+](C)C)cc4oc4c3ccc(c4)N(C)C)C(CC2N)O)N)C(C(C1O)N)O	GGCUUAGUAUAGCUAGGUUUAGCUACACUCGUGCUGAGCC	Tobramycin-CRT	Target_lig_993	J6fd6 RNA	Target_308	7.46852108295774
2194	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1OC1OC(CO)C(C(C1N)O)O)N)O	CUGUCUUCACGCAGAAAGCGUCUAGCCAUGGCGUUAGUAUGAGUGUCG	Compd 38	Target_lig_1160	HCV IRES Domain Iib	Target_408	4.92081875395238
1030	O1COc2c1cc(C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)NCCCN)CCCCN)CSSC[C@H](NC(=O)[C@@H]3CCCN3C(=O)c3cc4OCOc4cc3)C(=O)N[C@H](C(=O)NCCCN)CCCCN)CCC1)cc2	CCGCUGCUGCUGCUGCGG	ligand 3-3	Target_lig_621	RNA seq A	Target_151	5.267606240177031
1860	CN(C)CCCN=C(C1=CC=C(C=C1)C2=CC=C(O2)C3=NC4=C(N3)C=C(C=C4)C(=NCCCN(C)C)N)N	GGGAGAGGGUUUAAUUCAGUACGAAAGUACUGAUUGGAUCCGCAAGG	B3	Target_lig_246	(5'CAG/3'GUC) x1	Target_346	5.85387196432176
739	CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCOP(=O)(O)OP(=O)(O)[O-]	GGUAACCACUAGGGGUGUCCUUCAUAAGGGCUGAGAUAAAAGUGUGACUUUUAGACCCUCAUAACUUGAACAGGUUCAGACCUGCGUAGGGAAGUGGAGC	Thiamine_Pyrophosphate(TPP)	Target_lig_318	B.subtilis tenA TPP riboswitch	Target_76	7.30102999566398
1025	CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F	AUCACCUCCUUA	SL3 RNA_ligand17	Target_lig_620	single stranded RNA seq	Target_150	3.21896306137887
2421	CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CC=C(O3)CN)N)N)N)O	AUUUUUCCUCGAACCCGGCGGAACGCAGAAAAAU	sisomicin	Target_lig_10	U15C,U16C SLI_mutant	Target_441	7.397940008672039
2470	OCC1OC(OC2C(N)CC(C(C2O)OC2OC(CNC(=O)c3ccc(c(c3)C(=O)O)c3c4ccc(=[N+](C)C)cc4oc4c3ccc(c4)N(C)C)C(CC2N)O)N)C(C(C1O)N)O	CCCCCGCCACCUUCGGGUGGCCGGGG	CRT	Target_lig_993	TS mRNA Construct_5	Target_446	5.88306035344924
904	C1=CC=C(C=C1)C[C@@H]2[C@H](OC(=O)N2)COC(=O)CC3=CC=CC=C3	GAGGGUGGAAUCGCGCUUCGGCGUCCCUC	Oxazolidinone 6	Target_lig_544	T-box C11U	Target_114	3.90308998699194
914	OCc1ccc(cc1)CCc1ccc(cc1)CO[C@H]1[C@@H](C[C@H](N)[C@@H](O)[C@@H]1O)N	CGCGCGUGUGCGCG	DOS_der_4	Target_lig_549	RNA_XIX	Target_136	3.0
1417	CNC1C(OC2OC(Cn3nnc(c3)CCC(=O)Nc3cccc(c3)c3csc(n3)NC(=O)C)C(C(C2O)O)N)OC2C(C1O)OC(C(C2)N)OC1C(N)CC(C(C1O)O)N	GGGAUACUCAAAAUGGGGGCGCUUUCCUUUUUGUCUGUACUGGGAAGUGCUUCGAUUUUGGGGUGUCCC	Apramycin-6a	Target_lig_772	Pre-miR-373	Target_267	3.99567862621736
128	CC1=CC(=NC2=C1C=CC(=C2)N)N(C)C	GAGCGUCACACCUUCGGGUGAAGUCGCUC	2-N,2-N,4-trimethylquinoline-2,7-diamine	Target_lig_99	A-site 16S rRNA_E_coli (1)	Target_3	4.45593195564972
947	c12cc(ccc1c(c1c(n2)ccc(c1)OC)NCCCCc1c(nc(nc1N)N)N)Cl	CUGGCCUGGCGCGCCUGCCCAG	MBNL CCUG ligand 3	Target_lig_563	RNA B	Target_144	4.58502665202918
692	C1CNCCC1C2=NC3=CC(=C(C=C3N2CC4=CC=NC=C4)Cl)Cl	GAGCGUCACACCUUCGGGUGAAGUCGCUC	benzimidazole_analog_rRNA_35	Target_lig_451	16s_rRNA A SITE	Target_3	4.22184874961636
1060	CCCN(CC(=O)N(CCC)CC(=O)N(CC(N)=O)CC1=CN(CCCNC(=O)CCCOC2=C(C=C(C=C2C(C)(C)C)C2=NC3=CC(=CC=C3N2)N2CC[NH+](C)CC2)C(C)(C)C)N=N1)C(=O)CCCOC1=CC=CC(=C1)C1=NC2=CC(=CC=C2N1)C1=NC2=CC(=CC=C2N1)N1CC[NH+](C)CC1	GGGAGAGGGUUUAAUUACGAAAGUAAUUGGAUCCGCAAGG	Targaprimir-96	Target_lig_627	Pri-miR-96 RNAC  (UU loop mutant to AU basepair)	Target_159	5.397940008672039
1064	CCCN(CC(=O)N(CCC)CC(=O)N(CC(N)=O)CC1=CN(CCCNC(=O)CCCOC2=C(C=C(C=C2C(C)(C)C)C2=NC3=CC(=CC=C3N2)N2CC[NH+](C)CC2)C(C)(C)C)N=N1)C(=O)CCCOC1=CC=CC(=C1)C1=NC2=CC(=CC=C2N1)C1=NC2=CC(=CC=C2N1)N1CC[NH+](C)CC1	GGGAGAGGGUUUACGAUUUACGAAAGUAUAUCGUGGAUCCGCAAGG	Targaprimir-96	Target_lig_627	Pri-miR-96 RNA4 (GG to GC loop mutation)	Target_163	5.92081875395238
2245	CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CC=C(O3)CN)N)N)N)O	GCCAACCCACCUAACUACGGAAAACCUGAUCCC	sisomicin	Target_lig_10	human tyrosine sulfotransferase mRNA	Target_410	4.43179827593301
2179	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1OC1OC(CO)C(C(C1N)O)O)N)O	GAAGACAGCCGCUUCUACGAGCAU	Compd 38	Target_lig_1160	E. coli transglycosidase mRNA	Target_407	6.0
238	CN1CCN(CC1)C2=CC3=C(C=C2)N=C(N3)C4=CC5=C(C=C4)N=C(N5)C6=CC(=C(C(=C6)O)O)O	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	CMC3_Hoechst33258	Target_lig_179	HIV-1 TAR RNA	Target_19	5.0
1388	CCCCNC(=O)Nc1ccc2c(c1)nc(o2)Cc1nnn(c1)CC1OC(C(C1OC1OC(CN)C(C(C1N)O)O)O)OC1C(O)C(N)CC(C1OC1OC(CN)C(C(C1N)O)O)N	GUGGGCCUCAAAUGUGGAGCACUAUUCUGAUGUCCAAGUGGAAAGUGCUGCGACAUUUGAGCGUCAC	Neomycin_nucleobase_3g	Target_lig_757	Pre-miR-372	Target_266	4.70553377383841
2377	CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O	UUUUUUAGGGAAGAUCUGGCCUUCCCACAAGGGAAGGCCAGGGAAUUUUCUU	Idarubicin	Target_lig_1223	HIV-1FRAMESHIFT STEM LOOP STRUCTURE	Target_109	5.04095860767891
2224	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1OC1OC(CO)C(C(C1N)O)O)N)O	GGCUGACCAUCAAUAAGGAAGAAGCCCUUCAGCGGCCAGUA	Compd 38	Target_lig_1160	HIV protease active site (PAS) mRNA	Target_409	5.30102999566398
874	c12c(c(c3c(n1)cccc3)Nc1ccc(cc1)CNC(=O)[C@H](C(C)C)NC(=O)[C@H](NC(=O)CCCN)CO)cccc2C(=O)N[C@@H](C(=O)N)CCCNC(=N)N	GGGCGGUUUUUCGAAGCUUGAGUCUCGUAGAGGGCUUCGGCCUGGCGUAGACUGACGCUC	HTP 20	Target_lig_527	RNA aptamer_4	Target_59	7.045757490560679
1605	CN1CCN(CC1)c1ccc2c(c1)oc(=O)c(c2)c1cccc(c1)Cl	AAAAGAAGGAAGUGCUCACAUUCCUUAAAUUAAGGAGUAAGUCUGC	SMN2_compound_4	Target_lig_862	SMN2 pre-mRNA GA-rich sequence	Target_284	4.44490555142168
1339	C1=CC=C(C=C1)NCC(CN2C3=C(C=C(C=C3)Br)C4=C2C=CC(=C4)Br)O	GGGUUGACUGUUGAAUCUCAUGGCAACCC	Aniline_analog_10	Target_lig_734	miR-21 hairpin	Target_265	5.67778070526608
1583	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)O)O)OC3C(C(C(C(O3)CO)O)N)O)N	CCGACUGAUGUUGACUGUUGAAUCUCAUGGCAACACCAGUCGG	Kanamycin-A	Target_lig_1272	Oligonucleotide 3	Target_282	4.35654732351381
1779	CCCN(C(=O)CN(C(=O)CN(C(=O)CN(C(=O)CCCOc1cc(cc(c1)c1[nH]c2c(n1)cc(cc2)N)c1[nH]c2c(n1)ccc(c2)N)CCC)CCC)CCC)CC(=O)N(CC(=O)N)CCCn1cnc(c1)CN1CCN(CC1)c1nc(CC)nc(c1)Nc1nccc(c1)Nc1ccc2c(n1)cccc2	GCAGAGGUUGCCCUUGGUGAAUUCGCUUUAUUUAUGUUGAAUCACACAAAGGCAACUUUUGU	Targapremir-377	Target_lig_998	Pre-miR-377	Target_312	6.721246399047169
924	OCc1ccc(cc1)CCc1ccc(cc1)CO[C@H]1[C@@H](C[C@H](N)[C@@H](O)[C@@H]1O)N	CGCGCAGUAGUAGCGCG	DOS_der_4	Target_lig_549	RNA_XXI	Target_138	3.0
2439	CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CC=C(O3)CN)N)N)N)O	AUUUUUCCUCGAACUUGGUAGAACGCAGAAAAAU	sisomicin	Target_lig_10	C19U,G20A SLI_mutant	Target_443	7.52287874528034
393	CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CC=C(O3)CN)N)N)N)O	GGCCGAGUAGUGUUGGGUCGCGAAAGGCC	sisomicin	Target_lig_10	HCV IRES Domain IIId	Target_66	6.585026652029179
1774	OCC1OC(OC2C(N)CC(C(C2O)OC2OC(CNC(=O)c3ccc(c(c3)C(=O)O)c3c4ccc(=[N+](C)C)cc4oc4c3ccc(c4)N(C)C)C(CC2N)O)N)C(C(C1O)N)O	GGCUUAGUAUAGCGAGGUUUAGUUACACUCGUGCUGAGCC	Tobramycin-CRT	Target_lig_993	J6f17 RNA	Target_311	6.3763372926438
680	C1CNCCC1C2=NC3=NC=NC=C3N2	GAGCGUCACACCUUCGGGUGAAGUCGCUC	benzimidazole_analog_rRNA_23	Target_lig_439	16s_rRNA A SITE	Target_3	3.0390538042661697
872	c12c(c(c3c(n1)cccc3)Nc1ccc(cc1)CNC(=O)[C@H](C(C)C)NC(=O)[C@H](NC(=O)CCCN)CO)cccc2C(=O)N[C@@H](C(=O)N)CCCNC(=N)N	GGGCGGUUUUUCGAAGCUUGAGUCUUACGUAGAGGGCUUCGGCCUGGCGAUAGACUGACGCUC	HTP 20	Target_lig_527	RNA aptamer_2	Target_57	6.838631997765031
1785	NCCCCC(C(=O)OCOC[C@H]1OC(C[C@@H]1O)C(=O)Nc1cccc(c1)c1csc(n1)NC(=O)C)N	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	Compound 3aa	Target_lig_1003	HIV-1 TAR RNA	Target_19	4.85387196432176
945	c12cc(ccc1c(c1c(n2)ccc(c1)OC)NCCCCc1c(nc(nc1N)N)N)Cl	CCUGCCUGCCUGCCUGCCUGCCUG	MBNL CCUG ligand 3	Target_lig_563	(CCUG)6	Target_62	3.52287874528034
277	CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	chloro_methylpiperazinyl_propyl_phenothiazine_der	Target_lig_217	HIV-1 TAR RNA	Target_19	2.52287874528034
1433	CCCN(C(=O)CN(C(=O)CNCc1nnn(c1)N=[N+]=N)CCC)CC(=O)N(CC(=O)N(CC(=O)N(CC(=O)N)CCC)CCC)CCC	GGGAGAGGGUUUAAUUCAUUCUACGAAAGUAGCGUUAAUUGGAUCCGCAAGG	Compound 1a	Target_lig_780	Pri-miR-515 and the adjacent RNA motif (RNA 4)	Target_271	4.74472749489669
919	OCc1ccc(cc1)CCc1ccc(cc1)CO[C@H]1[C@@H](C[C@H](N)[C@@H](O)[C@@H]1O)N	CGCGCAGUGUAGCGCG	DOS_der_4	Target_lig_549	RNA_XX	Target_137	3.0
1034	O1COc2c1cc(C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)NCCCN)CCCCN)CSSC[C@H](NC(=O)[C@@H]3CCCN3C(=O)c3cc4OCOc4cc3)C(=O)N[C@H](C(=O)NCCCN)CCCCN)CCC1)cc2	CCGCUGCUGCUGCUGCGG	ligand 3-3	Target_lig_621	RNA seq A (20 x t-RNA)	Target_152	4.85387196432176
871	c12c(c(c3c(n1)cccc3)Nc1ccc(cc1)CNC(=O)[C@H](C(C)C)NC(=O)[C@H](NC(=O)CCCN)CO)cccc2C(=O)N[C@@H](C(=O)N)CCCNC(=N)N	GGGCGGUUUUUCGAAGCUUGAGUCUCGUAGAGGGCUUCGGCCUGGCGAAUUAGACUGACGCUC	HTP 20	Target_lig_527	RNA aptamer_1	Target_56	7.67778070526608
1170	CC1=NC=CC2=C1NC3=CC=CC=C23	GUAUAUGGUAAACUAUGAAAAAACACGAUUCGGUUGGUAGUCCGGAUGCAUGAUUGAGAAUGUCAGUAACCUUCCCCUCCUCGGGAUGUCCAUCAUUCUUUAAUAUCU	Harmane	Target_lig_668	108 nt yjdF Riboswitch Construct, B. subtilis, Mutant 1	Target_195	7.0
352	[C@@H]1([C@H]([C@H]([C@H](O[C@H]1CNNC(=O)OC(C)(C)C)O[C@H]1[C@@H]([C@H]([C@H](C[C@H]1N)N)O)O[C@H]1O[C@@H]([C@H]([C@@H]1O)O[C@@H]1CO[C@H]([C@@H]([C@H]1O)O)CN)CO)N)O)O	GAGCGUCACACCUUCGGGUGAAGUCGCUC	Perazidoparomomycin derivative 4	Target_lig_278	Bacterial ribosomal A-site	Target_3	8.0
1581	CNC1C(OC2OC(Cn3nnc(c3)CCC(=O)Nc3cccc(c3)c3csc(n3)NC(=O)C)C(C(C2O)O)N)OC2C(C1O)OC(C(C2)N)OC1C(N)CC(C(C1O)O)N	CCGACUGAUGUUGACUGUUGAAUCUCAUGGCAACACCAGUCGG	Apramycin	Target_lig_772	Oligonucleotide 3	Target_282	4.657577319177791
271	c1c(ccc2Sc3ccccc3N(c12)CCCN[C@H](CCSC)O)C(=O)C	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	3_phenothiazine_analog_2	Target_lig_211	HIV-1 TAR RNA	Target_19	2.30102999566398
1594	CCNC1CC(C(C(C1OC2C(C(C(CO2)(C)O)NC)O)O)OC3C(CC=C(O3)CN)N)N	CCGACUGAUGUUGAXUGUUGAAUYUCAUGGCAACACCAGUCGG	Netilmicin	Target_lig_1271	Oligonucleotide 4	Target_283	4.46852108295774
685	C1CNCCC1C2=NC3=CC(=C(C=C3N2CC4=C(C(=C(C(=C4F)F)C(F)(F)F)F)F)Cl)Cl	GAGCGUCACACCUUCGGGUGAAGUCGCUC	benzimidazole_analog_rRNA_28	Target_lig_444	16s_rRNA A SITE	Target_3	3.93181413825384
1061	CCCN(CC(=O)N(CCC)CC(=O)N(CC(N)=O)CC1=CN(CCCNC(=O)CCCOC2=C(C=C(C=C2C(C)(C)C)C2=NC3=CC(=CC=C3N2)N2CC[NH+](C)CC2)C(C)(C)C)N=N1)C(=O)CCCOC1=CC=CC(=C1)C1=NC2=CC(=CC=C2N1)C1=NC2=CC(=CC=C2N1)N1CC[NH+](C)CC1	GGGAGAGGGUUUAUUUACGAAAGUAUAUGGAUCCGCAAGG	Targaprimir-96	Target_lig_627	Pri-miR-96 RNA1 (Drosha processing site only)	Target_160	5.92081875395238
1372	CCOc1ccc(cc1)NCC(Cn1c2cc(Br)ccc2c2c1cc(Br)cc2)O	GGGUUGACUGUUGAAUCUCAUGGCAACCC	Carbazole_analog_20	Target_lig_742	miR-21 hairpin	Target_265	6.0
414	CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCOP(=O)(O)OP(=O)(O)[O-]	GGUAACCACUAGGGGUGUCCUUCAUAAGGGCUGAGAUAAAAGUGUGACUUUUAGACCCUCAUAACUUGAACAGGUUCAGACCUGCGUAGGGAAGUGGAGC	Thiamine_Pyrophosphate(TPP)	Target_lig_318	TPP RIBOSWITCH APTAMER	Target_37	6.30539480106643
2498	O=C(Cc1ccccc1)OCC1OC(=O)N[C@H]1CN1CCN(CC1)c1ccccc1	GAGGGUGGAACCGCGCUUCGGCGUCCCUC	Compound (4S,5R)-1	Target_lig_1240	Antiterminator model RNA AM1A	Target_147	4.79588001734408
2050	NCCCOc1ccc(cc1CNCCCCNC(=N)N)c1cc2c(o1)cccc2	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	Rbt429	Target_lig_1125	HIV-1 TAR RNA	Target_19	6.721246399047169
1063	CCCN(CC(=O)N(CCC)CC(=O)N(CC(N)=O)CC1=CN(CCCNC(=O)CCCOC2=C(C=C(C=C2C(C)(C)C)C2=NC3=CC(=CC=C3N2)N2CC[NH+](C)CC2)C(C)(C)C)N=N1)C(=O)CCCOC1=CC=CC(=C1)C1=NC2=CC(=CC=C2N1)C1=NC2=CC(=CC=C2N1)N1CC[NH+](C)CC1	GGGAGAGGGUUUACGAUUUACGAAAGUAUAUGGUGGAUCCGCAAGG	Targaprimir-96	Target_lig_627	Pri-miR-96 RNA3 (both the Drosha target site and adjacent target site)	Target_162	4.69897000433602
673	C1CNCCC1C2=NC3=C(N2)C=C(C=C3)Cl	GAGCGUCACACCUUCGGGUGAAGUCGCUC	benzimidazole_analog_rRNA_16	Target_lig_433	16s_rRNA A SITE	Target_3	3.29413628771608
375	[C@@H]1([C@@H]([C@H]([C@@H](C[C@@H]1CO)O[C@@H]1[C@H]([C@H]([C@@H](C[C@@H]1N)N)O)O[C@H]1O[C@H]([C@H]([C@@H]1OCCN(CCc1ccccc1)C(=O)C)O[C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)N)O)O)N)CO)N)O)O	GAGCGUCACACCUUCGGGUGAAGUCGCUC	Ether paromomycin derivative 1	Target_lig_1112	Bacterial ribosomal A-site	Target_3	6.045757490560679
991	C1=CC=C2C=C(C=CC2=C1)/C=C/3\C(=O)N=C(S3)N	AGGACUCGGCUUGCUGAAGCGCGCGACGGCAAGAGGCGAGGGGCGGCGACUGGUGAGUACGCCAAAAAUUUUGACUAGCGGAGGCUAGAAGGAGAGAGAUGGGUGCGAGAGCGUCGGU	SL3 RNA_ligand3	Target_lig_606	SL3 RNA	Target_146	4.958607314841769
1065	CCCN(CC(=O)N(CCC)CC(=O)N(CC(N)=O)CC1=CN(CCCNC(=O)CCCOC2=C(C=C(C=C2C(C)(C)C)C2=NC3=CC(=CC=C3N2)N2CC[NH+](C)CC2)C(C)(C)C)N=N1)C(=O)CCCOC1=CC=CC(=C1)C1=NC2=CC(=CC=C2N1)C1=NC2=CC(=CC=C2N1)N1CC[NH+](C)CC1	GGGAGAGGGUUUACGAUUUACGAAAGUAAAUGGUGGAUCCGCAAGG	Targaprimir-96	Target_lig_627	Pri-miR-96 RNA5 (UU loop mutant to UA loop)	Target_164	5.82390874094432
1848	CN(C)CCCN=C(C1=CC=C(C=C1)C2=CC=C(O2)C3=NC4=C(N3)C=C(C=C4)C(=NCCCN(C)C)N)N	GGGAGAGGGUUUAAUUCGGUACGAAAGUACGGAUUGGAUCCGCAAGG	B3	Target_lig_246	(5'CGG/3'GGC) x1	Target_345	5.455931955649719
1371	OC(Cn1c2ccc(cc2c2c1cccc2)Br)CNc1ccc(cc1)N1CCOCC1	GGGUUGACUGUUGAAUCUCAUGGCAACCC	Carbazole_analog_19	Target_lig_741	miR-21 hairpin	Target_265	5.49485002168009
2253	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1OC1OC(CO)C(C(C1N)O)O)N)O	GCCAACCCACCUAACUACGGAAAACCUGAUCCC	Compd 38	Target_lig_1160	human tyrosine sulfotransferase mRNA	Target_410	4.85387196432176
357	[C@H]1([C@H]([C@H]([C@H](O[C@@H]1CNCCc1ccccc1)O[C@H]1[C@@H]([C@H]([C@H](C[C@H]1N)N)O)O[C@H]1O[C@@H]([C@@H]([C@@H]1O)O[C@H]1CO[C@@H]([C@@H]([C@H]1O)O)CN)CO)N)O)O	GAGCGUCACACCUUCGGGUGAAGUCGCUC	Perazidoparomomycin derivative 10	Target_lig_283	Bacterial ribosomal A-site	Target_3	6.30102999566398
808	CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CC=C(O3)CN)N)N)N)O	AUUUUUCCUCGAACUUGGCGGAACGCAGAAAAAU	sisomicin	Target_lig_10	SLI of Rep A	Target_127	7.52287874528034
1155	CCC1=C(C=C2C=C3C=CC=CC3=CC2=N1)C(=O)N(C)[C@@H](CCN1C=C(C[C@H](N(C)C(=O)C2=C(CC)N=C3C=C4C=CC=CC4=CC3=C2)C(=O)N2CCC[C@H]2C(=O)N(C)[C@@H](CC2=CC=CC=C2)C(=O)NCCC[NH3+])N=N1)C(=O)N1CCC[C@H]1C(=O)N(C)[C@@H](CC1=CC=CC=C1)C(=O)NCCC[NH3+]	UUUUUUAGGGAAGAUCUGGCCUUCCCACAAGGGAAGGCCAGGGAAUUUUCUU	DCC 7 (2017)	Target_lig_661	HIV-1 FSS RNA	Target_109	7.79588001734408
1369	C1=CC=C(C=C1)NCC(CN2C3=CC=CC=C3C4=CC=CC=C42)O	GGGUUGACUGUUGAAUCUCAUGGCAACCC	Carbazole_analog_17	Target_lig_739	miR-21 hairpin	Target_265	5.08092190762393
667	c1c(cc2c(c1)[nH]c(n2)[C@H]1C[C@H](CCC1)N)N(=O)O	GAGCGUCACACCUUCGGGUGAAGUCGCUC	benzimidazole_analog_rRNA_10	Target_lig_427	16s_rRNA A SITE	Target_3	3.6556077263148894
1403	CNC1C(OC2OC(Cn3nnc(c3)CCC(=O)Nc3cccc(c3)c3csc(n3)NC(=O)C)C(C(C2O)O)N)OC2C(C1O)OC(C(C2)N)OC1C(N)CC(C(C1O)O)N	GUGGGCCUCAAAUGUGGAGCACUAUUCUGAUGUCCAAGUGGAAAGUGCUGCGACAUUUGAGCGUCAC	Apramycin-6a	Target_lig_772	Pre-miR-372	Target_266	3.68193666503724
1593	CNC1C(OC2OC(Cn3nnc(c3)CCC(=O)Nc3cccc(c3)c3csc(n3)NC(=O)C)C(C(C2O)O)N)OC2C(C1O)OC(C(C2)N)OC1C(N)CC(C(C1O)O)N	CCGACUGAUGUUGAXUGUUGAAUYUCAUGGCAACACCAGUCGG	Apramycin	Target_lig_772	Oligonucleotide 4	Target_283	4.6382721639824105
273	c1cccc2Sc3ccc(cc3N(c12)CCCNCCCCC)Cl	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	2-chloro-10-pyrrolidin_phenothiazine_der	Target_lig_213	HIV-1 TAR RNA	Target_19	3.25963731050576
638	C1[C@@H](N)[C@H](O)[C@H]([C@@H]([C@H]1N)OCSc1ccnc2c1ccc(c2)C(F)(F)F)O[C@@H]1O[C@@H]([C@H]([C@H]1O)O[C@H]1[C@@H]([C@H]([C@@H]([C@@H](O1)CN)O)O)N)CO	GAGCGUCACACCUUCGGGUGAAGUCGCUC	Quinolinyl_DOS_paromomycin_der_1	Target_lig_384	16s_rRNA A SITE	Target_3	6.0
1582	CCNC1CC(C(C(C1OC2C(C(C(CO2)(C)O)NC)O)O)OC3C(CC=C(O3)CN)N)N	CCGACUGAUGUUGACUGUUGAAUCUCAUGGCAACACCAGUCGG	Netilmicin	Target_lig_1271	Oligonucleotide 3	Target_282	4.45593195564972
1054	O1COc2c1cc(C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)NCCCN)CCCCN)CSSC[C@H](NC(=O)[C@@H]3CCCN3C(=O)c3cc4OCOc4cc3)C(=O)N[C@H](C(=O)NCCCN)CCCCN)CCC1)cc2	GGCCUUCCCACAAGGGAAGGCC	ligand 3-3	Target_lig_621	RNA seq F	Target_157	4.38721614328026
2149	NCC1OC(OC2C(N)CC(C(C2O)OC2OC(CN)C(CC2N)O)N)C(C(C1OC1OC(CO)C(C(C1N)O)O)N)O	GGCCGAGUAGUGUUGGGUCGCGAAAGGCC	Compd 38	Target_lig_1160	HCV IRES Domain IIId	Target_66	5.6382721639824105
250	CN1C=C(C(=O)C2=CC(=C(C=C21)N3CCN(CC3)C4=CC=CC=N4)N)C(=O)O	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	Wm5	Target_lig_191	HIV-1 TAR RNA	Target_19	7.721246399047169
1927	CC(C)OC(=O)C1=CC=C(C=C1)NC2=NC3=CC=CC=C3C4=NN=CN42	UGUGGGAGGGGCGGGUCUGGG	Hit S11	Target_lig_1076	NRAS G4 motif	Target_259	4.0
1066	CCCN(CC(=O)N(CCC)CC(=O)N(CC(N)=O)CC1=CN(CCCNC(=O)CCCOC2=C(C=C(C=C2C(C)(C)C)C2=NC3=CC(=CC=C3N2)N2CC[NH+](C)CC2)C(C)(C)C)N=N1)C(=O)CCCOC1=CC=CC(=C1)C1=NC2=CC(=CC=C2N1)C1=NC2=CC(=CC=C2N1)N1CC[NH+](C)CC1	CGCGAATTCGCGTTTTCGCGAATTCGCG	Targaprimir-96	Target_lig_627	Pri-miR-96 AT-rich DNA hairpin	Target_165	4.30102999566398
1595	C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)O)O)OC3C(C(C(C(O3)CO)O)N)O)N	CCGACUGAUGUUGAXUGUUGAAUYUCAUGGCAACACCAGUCGG	Kanamycin-A	Target_lig_1272	Oligonucleotide 4	Target_283	4.3467874862246605
1251	CC(=O)NC1=NC(=CS1)C1=CC(NC(=O)[C@@H]([NH3+])CCCC[NH3+])=CC=C1	GGCAGAUCUGAGCCUGGGAGCUCUCUGCC	S-Amino acid conjugate 1b	Target_lig_698	HIV-1 TAR	Target_19	5.1249387366083
693	C1CNCCC1C2=NC3=CC(=C(C=C3N2CC4=CN=CC=C4)Cl)Cl	GAGCGUCACACCUUCGGGUGAAGUCGCUC	benzimidazole_analog_rRNA_36	Target_lig_452	16s_rRNA A SITE	Target_3	4.1739251972991696
1823	CCCN(C(=O)CN(C(=O)NCc1nnn(c1)CCCCC(=O)CCCOc1c(cc(cc1C(C)(C)C)c1nc2c([nH]1)ccc(c2)c1ccc(cc1)N1CCN(CC1)C)C(C)(C)C)CCC)CC(=O)N(CC(=O)N(Cc1nnn(c1)CCCCC(=O)CCCOc1c(cc(cc1C(C)(C)C)c1nc2c([nH]1)ccc(c2)c1ccc(cc1)N1CCN(CC1)C)C(C)(C)C)CC(=O)N)CCC	UAGCUUAUCAGACUGAUGUUGACUGUUGAAUCUCAUGGCAACACCAGUCGAUGGGCUGU	SMB4	Target_lig_1279	Pre-miR-17/18a/20a	Target_331	6.92081875395238
339	[C@H]1([C@@H]([C@H]([C@@H](O[C@H]1CO)O[C@H]1[C@@H]([C@H]([C@@H](C[C@@H]1N)N)O)O[C@@H]1OC[C@@H]([C@H]1OCCNCc1ccccc1)O[C@@H]1[C@H]([C@@H](C[C@@H](O1)CN)O)N)N)O)O	GAGCGUCACACCUUCGGGUGAAGUCGCUC	Aminoglycoside derivative 16	Target_lig_265	Bacterial ribosomal A-site	Target_3	7.0
1772	OCC1OC(OC2C(N)CC(C(C2O)OC2OC(CNC(=O)c3ccc(c(c3)C(=O)O)c3c4ccc(=[N+](C)C)cc4oc4c3ccc(c4)N(C)C)C(CC2N)O)N)C(C(C1O)N)O	GGCUUAGUAUAGCGAGGUUUAACUACACUCGUGCUGAGCC	Tobramycin-CRT	Target_lig_993	J6f16 RNA	Target_310	7.221848749616361
902	C1=CC=C(C=C1)C[C@@H]2[C@H](OC(=O)N2)COC(=O)CC3=CC=CC=C3	GAGGGUGGAACCGCGCUUCGGCGUCCCUC	Oxazolidinone 6	Target_lig_544	T-box RNA	Target_113	5.045757490560679
1770	OCC1OC(OC2C(N)CC(C(C2O)OC2OC(CNC(=O)c3ccc(c(c3)C(=O)O)c3c4ccc(=[N+](C)C)cc4oc4c3ccc(c4)N(C)C)C(CC2N)O)N)C(C(C1O)N)O	GGCUUAGUAUAGCGAGGUUUGGCUACACUCGUGCUGAGCC	Tobramycin-CRT	Target_lig_993	J6f15 RNA	Target_309	6.3707943428977
223	C1=C(N=C(N=C1N)N)N	GGACAUAUAAUCGCGUGGAUAUGGCACGCAAGUUUCUACCGGGCACCGUAAAUGUCCGAUUAUGUCC	2,4,6-triaminopyrimidine	Target_lig_167	ADENINE RIBOSWITCH	Target_69	4.69897000433602
608	[C@H]1([C@@H]([C@@H]([C@@H](O[C@H]1CN)O[C@H]1[C@H]([C@H]([C@H](C[C@@H]1N)N)O)OC[C@@H](CN(CCCCN(C[C@@H](CO[C@H]1[C@@H]([C@H](C[C@H]([C@@H]1O)N)N)O[C@H]1[C@H]([C@@H]([C@@H]([C@@H](O1)CN)O)O)N)O)C)C)O)N)O)O	GAGCGUCACACCUUCGGGUGAAGUCGCUC	Bifunctional_aminoglycoside_derivative_2	Target_lig_354	16s_rRNA A SITE	Target_3	7.397940008672039
298	CCN(CC)CCSCC(=O)OC1CC(C(C(C23CCC(C1(C2C(=O)CC3)C)C)C)O)(C)C=C	UUGGCUACUAUGCCAGCUGGUGGAUUGCUCGGCUCAGGCGCUGAUGAAGGACGUGCCAAGCUGCGAUAAGCCAUGGGGAGCCGCACGGAGGCGAAGAACCAUGGAUUUCCGAAUGAGAAUCUCUCUAACAAUUGCUUCGCGCAAUGAGGAACCCCGAGAACUGAAACAUCUCAGUAUCGGGAGGAACAGAAAACGCAAUGUGAUGUCGUUAGUAACCGCGAGUGAACGCGAUACAGCCCAAACCGAAGCCCUCACGGGCAAUGUGGUGUCAGGGCUACCUCUCAUCAGCCGACCGUCUCGACGAAGUCUCUUGGAACAGAGCGUGAUACAGGGUGACAACCCCGUACUCGAGACCAGUACGACGUGCGGUAGUGCCAGAGUAGCGGGGGUUGGAUAUCCCUCGCGAAUAACGCAGGCAUCGACUGCGAAGGCUAAACACAACCUGAGACCGAUAGUGAACAAGUAGUGUGAACGAACGCUGCAAAGUACCCUCAGAAGGGAGGCGAAAUAGAGCAUGAAAUCAGUUGGCGAUCGAGCGACAGGGCAUACAAGGUCCCUCGACGAAUGACCGACGCGCGAGCGUCCAGUAAGACUCACGGGAAGCCGAUGUUCUGUCGUACGUUUUGAAAAACGAGCCAGGGAGUGUGUCUGCAUGGCAAGUCUAACCGGAGUAUCCGGGGAGGCACAGGGAAACCGACAUGGCCGCAGGGCUUUGCCCGAGGGCCGCCGUCUUCAAGGGCGGGGAGCCAUGUGGACACGACCCGAAUCCGGACGAUCUACGCAUGGACAAGAUGAAGCGUGCCGAAAGGCACGUGGAAGUCUGUUAGAGUUGGUGUCCUACAAUACCCUCUCGUGAUCUAUGUGUAGGGGUGAAAGGCCCAUCGAGUCCGGCAACAGCUGGUUCCAAUCGAAACAUGUCGAAGCAUGACCUCCGCCGAGGUAGUCUGUGAGGUAGAGCGACCGAUUGGUGUGUCCGCCUCCGAGAGGAGUCGGCACACCUGUCAAACUCCAAACUUACAGACGCCGUUUGACGCGGGGAUUCCGGUGCGCGGGGUAAGCCUGUGUACCAGGAGGGGAACAACCCAGAGAUAGGUUAAGGUCCCCAAGUGUGGAUUAAGUGUAAUCCUCUGAAGGUGGUCUCGAGCCCUAGACAGCCGGGAGGUGAGCUUAGAAGCAGCUACCCUCUAAGAAAAGCGUAACAGCUUACCGGCCGAGGUUUGAGGCGCCCAAAAUGAUCGGGACUCAAAUCCACCACCGAGACCUGUCCGUACCACUCAUACUGGUAAUCGAGUAGAUUGGCGCUCUAAUUGGAUGGAAGUAGGGGUGAAAACUCCUAUGGACCGAUUAGUGACGAAAAUCCUGGCCAUAGUAGCAGCGAUAGUCGGGUGAGAACCCCGACGGCCUAAUGGAUAAGGGUUCCUCAGCACUGCUGAUCAGCUGAGGGUUAGCCGGUCCUAAGUCAUACCGCAACUCGACUAUGACGAAAUGGGAAACGGGUUAAUAUUCCCGUGCCACUAUGCAGUGAAAGUUGACGCCCUGGGGUCGAUCACGCUGGGCAUUCGCCCAGUCGAACCGUCCAACUCCGUGGAAGCCGUAAUGGCAGGAAGCGGACGAACGGCGGCAUAGGGAAACGUGAUUCAACCUGGGGCCCAUGAAAAGACGAGCAUAGUGUCCGUACCGAGAACCGACACAGGUGUCCAUGGCGGCGAAAGCCAAGGCCUGUCGGGAGCAACCAACGUUAGGGAAUUCGGCAAGUUAGUCCCGUACCUUCGGAAGAAGGGAUGCCUGCUCCGGAACGGAGCAGGUCGCAGUGACUCGGAAGCUCGGACUGUCUAGUAACAACAUAGGUGACCGCAAAUCCGCAAGGACUCGUACGGUCACUGAAUCCUGCCCAGUGCAGGUAUCUGAACACCUCGUACAAGAGGACGAAGGACCUGUCAACGGCGGGGGUAACUAUGACCCUCUUAAGGUAGCGUAGUACCUUGCCGCAUCAGUAGCGGCUUGCAUGAAUGGAUUAACCAGAGCUUCACUGUCCCAACGUUGGGCCCGGUGAACUGUACAUUCCAGUGCGGAGUCUGGAGACACCCAGGGGGAAGCGAAGACCCUAUGGAGCUUUACUGCAGGCUGUCGCUGAGACGUGGUCGCCGAUGUGCAGCAUAGGUAGGAGACACUACACAGGUACCCGCGCUAGCGGGCCACCGAGUCAACAGUGAAAUACUACCCGUCGGUGACUGCGACUCUCACUCCGGGAGGAGGACACCGAUAGCCGGGCAGUUUGACUGGGGCGGUACGCGCUCGAAAAGAUAUCGAGCGCGCCCUAUGGCUAUCUCAGCCGGGACAGAGACCCGGCGAAGAGUGCAAGAGCAAAAGAUAGCUUGACAGUGUUCUUCCCAACGAGGAACGCUGACGCGAAAGCGUGGUCUAGCGAACCAAUUAGCCUGCUUGAUGCGGGCAAUUGAUGACAGAAAAGCUACCCUAGGGAUAACAGAGUCGUCACUCGCAAGAGCACAUAUCGACCGAGUGGCUUGCUACCUCGAUGUCGGUUCCCUCCAUCCUGCCCGUGCAGAAGCGGGCAAGGGUGAGGUUGUUCGCCUAUUAAAGGAGGUCGUGAGCUGGGUUUAGACCGUCGUGAGACAGGUCGGCUGCUAUCUACUGGGUGUGUAAUGGUGUCUGACAAGAACGACCGUAUAGUACGAGAGGAACUACGGUUGGUGGCCACUGGUGUACCGGUUGUUCGAGAGAGCACGUGCCGGGUAGCCACGCCACACGGGGUAAGAGCUGAACGCAUCUAAGCUCGAAACCCACUUGGAAAAGAGACACCGCCGAGGUCCCGCGUACAAGACGCGGUCGAUAGACUCGGGGUGUGCGCGUCGAGGUAACGAGACGUUAAGCCCACGAGCACUAACAGACCAAAGCCAUCAU	Tiamulin	Target_lig_236	PTC	Target_99	6.82681373158773
755	CCC1=NC2=CC=CC=C2C=C1C(=O)N3CCC[C@H]3C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)NCCCN)NC(=O)[C@@H]4CCCN4C(=O)C5=CC6=CC=CC=C6N=C5CC)C(=O)N[C@@H](CCCCN)C(=O)NCCCN	GCGCUGCUGCUGCUGCUGCUGCUGCUGCUGCUGCGC	hexanamide derivative_3	Target_lig_513	r(CUG)	Target_55	5.0
2452	OCC1OC(OC2C(N)CC(C(C2O)OC2OC(CNC(=O)c3ccc(c(c3)C(=O)O)c3c4ccc(=[N+](C)C)cc4oc4c3ccc(c4)N(C)C)C(CC2N)O)N)C(C(C1O)N)O	CCCCCCCGCCGCGCCAUGCCUGUGGCCGGUCGG	CRT	Target_lig_993	Thymidylate synthase m-RNA	Target_63	6.08884239126002
407	CC(=S)NC[C@@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCS(=O)CC3)F	GGUUAAGCGACUAAGCGUACACGGUGGAUGCCCUGGCAGUCAGAGGCGAUGAAGGACGUGCUAAUCUGCGAUAAGCGUCGGUAAGGUGAUAUGAACCGUUAUAACCGGCGAUUUCCGAAUGGGGAAACCCAGUGUGUUUCGACACACUAUCAUUAACUGAAUCCAUAGGUUAAUGAGGCGAACCGGGGGAACUGAAACAUCUAAGUACCCCGAGGAAAAGAAAUCAACCGAGAUUCCCCCAGUAGCGGCGAGCGAACGGGGAGCAGCCCAGAGCCUGAAUCAGUGUGUGUGUUAGUGGAAGCGUCUGGAAAGGCGCGCGAUACAGGGUGACAGCCCCGUACACAAAAAUGCACAUGCUGUGAGCUCGAUGAGUAGGGCGGGACACGUGGUAUCCUGUCUGAAUAUGGGGGGACCAUCCUCCAAGGCUAAAUACUCCUGACUGACCGAUAGUGAACCAGUACCGUGAGGGAAAGGCGAAAAGAACCCCGGCGAGGGGAGUGAAAAAGAACCUGAAACCGUGUACGUACAAGCAGUGGGAGCACGCUUAGGCGUGUGACUGCGUACCUUUUGUAUAAUGGGUCAGCGACUUAUAUUCUGUAGCAAGGUUAACCGAAUAGGGGAGCCGAAGGGAAACCGAGUCUUAACUGGGCGUUAAGUUGCAGGGUAUAGACCCGAAACCCGGUGAUCUAGCCAUGGGCAGGUUGAAGGUUGGGUAACACUAACUGGAGGACCGAACCGACUAAUGUUGAAAAAUUAGCGGAUGACUUGUGGCUGGGGGUGAAAGGCCAAUCAAACCGGGAGAUAGCUGGUUCUCCCCGAAAGCUAUUUAGGUAGCGCCUCGUGAAUUCAUCUCCGGGGGUAGAGCACUGUUUCGGCAAGGGGGUCAUCCCGACUUACCAACCCGAUGCAAACUGCGAAUACCGGAGAAUGUUAUCACGGGAGACACACGGCGGGUGCUAACGUCCGUCGUGAAGAGGGAAACAACCCAGACCGCCAGCUAAGGUCCCAAAGUCAUGGUUAAGUGGGAAACGAUGUGGGAAGGCCCAGACAGCCAGGAUGUUGGCUUAGAAGCAGCCAUCAUUUAAAGAAAGCGUAAUAGCUCACUGGUCGAGUCGGCCUGCGCGGAAGAUGUAACGGGGCUAAACCAUGCACCGAAGCUGCGGCAGCGACGCUUAUGCGUUGUUGGGUAGGGGAGCGUUCUGUAAGCCUGCGAAGGUGUGCUGUGAGGCAUGCUGGAGGUAUCAGAAGUGCGAAUGCUGACAUAAGUAACGAUAAAGCGGGUGAAAAGCCCGCUCGCCGGAAGACCAAGGGUUCCUGUCCAACGUUAAUCGGGGCAGGGUGAGUCGACCCCUAAGGCGAGGCCGAAAGGCGUAGUCGAUGGGAAACAGGUUAAUAUUCCUGUACUUGGUGUUACUGCGAAGGGGGGACGGAGAAGGCUAUGUUGGCCGGGCGACGGUUGUCCCGGUUUAAGCGUGUAGGCUGGUUUUCCAGGCAAAUCCGGAAAAUCAAGGCUGAGGCGUGAUGACGAGGCACUACGGUGCUGAAGCAACAAAUGCCCUGCUUCCAGGAAAAGCCUCUAAGCAUCAGGUAACAUCAAAUCGUACCCCAAACCGACACUGGUGGUCAGGUAGAGAAUACCAAGGCGCUUGAGAGAACUCGGGUGAAGGAACUAGGCAAAAUGGUGCCGUAACUUCGGGAGAAGGCACGCUGAUAUGUAGGUGAGGUCCCUCGCGGAUGGAGCUGAAAUCAGUCGAAGAUACCAGCUGGCUGCAACUGUUUAUUAAAAACACAGCACUGUGCAAACACGAAAGUGGACGUAUACGGUGUGACGCCUGCCCGGUGCCGGAAGGUUAAUUGAUGGGGUUAGCGCAAGCGAAGCUCUUGAUCGAAGCCCCGGUAAACGGCGGCCGUAACUAUAACGGUCCUAAGGUAGCGAAAUUCCUUGUCGGGUAAGUUCCGACCUGCACGAAUGGCGUAAUGAUGGCCAGGCUGUCUCCACCCGAGACUCAGUGAAAUUGAACUCGCUGUGCAGAUGCAGUGUACCCGCGGCAAGACGGAAAGACCCCGUGAACCUUUACUAUAGCUUGACACUGAACAUUGAGCCUUGAUGUGUAGGAUAGGUGGGAGGCUUUGAAGUGUGGACGCCAGUCUGCAUGGAGCCGACCUUGAAAUACCACCCUUUAAUGUUUGAUGUUCUAACGUUGACCCGUAAUCCGGGUUGCGGACAGUGUCUGGUGGGUAGUUUGACUGGGGCGGUCUCCUCCUAAAGAGUAACGGAGGAGCACGAAGGUUGGCUAAUCCUGGUCGGACAUCAGGAGGUUAGUGCAAUGGCAUAAGCCAGCUUGACUGCGAGCGUGACGGCGCGAGCAGGUGCGAAAGCAGGUCAUAGUGAUCCGGUGGUUCUGAAUGGAAGGGCCAUCGCUCAACGGAUAAAAGGUACUCCGGGGAUAACAGGCUGAUACCGCCCAAGAGUUCAUAUCGACGGCGGUGUUUGGCACCUCGAUGUCGGCUCAUCACAUCCUGGGGCUGAAGUAGGUCCCAAGGGUAUGGCUGUUCGCCAUUUAAAGUGGUACGCGAGCUGGGUUUAGAACGUCGUGAGACAGUUCGGUCCCUAUCUGCCGUGGGCGCUGGAGAACUGAGGGGGGCUGCUCCUAGUACGAGAGGACCGGAGUGGACGCAUCACUGGUGUUCGGGUUGUCAUGCCAAUGGCACUGCCCGGUAGCUAAAUGCGGAAGAGAUAAGUGCUGAAAGCAUCUAAGCACGAAACUUGCCCCGAGAUGAGUUCUCCCUGACCCUUUAAGGGUCCUGAAGGAACGUUGAAGACGACGACGUUGAUAGGCCGGGUGUGUAAGCGCAGCGAUGCGUUGAGCUAACCGGUACUAAUGAACCGUGAGGCUUAACCUU	LINEZOLID_DERIVATIVE_3	Target_lig_328	23SrRNA	Target_104	4.0268721464003
2448	CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CC=C(O3)CN)N)N)N)O	AUUUUUCCUCGAACUUGGCGAGACGCAGAAAAAU	sisomicin	Target_lig_10	G21A,A22G SLI_mutant	Target_444	7.221848749616361
2104	CC1CC=CC=CC(C(CC(C(C(C(CC(=O)O1)O)OC)OC2C(C(C(C(O2)C)OC3CC(C(C(O3)C)O)(C)C)N(C)C)O)CC=O)C)O	GGUUAAGCGACUAAGCGUACACGGUGGAUGCCCUGGCAGUCAGAGGCGAUGAAGGACGUGCUAAUCUGCGAUAAGCGUCGGUAAGGUGAUAUGAACCGUUAUAACCGGCGAUUUCCGAAUGGGGAAACCCAGUGUGUUUCGACACACUAUCAUUAACUGAAUCCAUAGGUUAAUGAGGCGAACCGGGGGAACUGAAACAUCUAAGUACCCCGAGGAAAAGAAAUCAACCGAGAUUCCCCCAGUAGCGGCGAGCGAACGGGGAGCAGCCCAGAGCCUGAAUCAGUGUGUGUGUUAGUGGAAGCGUCUGGAAAGGCGCGCGAUACAGGGUGACAGCCCCGUACACAAAAAUGCACAUGCUGUGAGCUCGAUGAGUAGGGCGGGACACGUGGUAUCCUGUCUGAAUAUGGGGGGACCAUCCUCCAAGGCUAAAUACUCCUGACUGACCGAUAGUGAACCAGUACCGUGAGGGAAAGGCGAAAAGAACCCCGGCGAGGGGAGUGAAAAAGAACCUGAAACCGUGUACGUACAAGCAGUGGGAGCACGCUUAGGCGUGUGACUGCGUACCUUUUGUAUAAUGGGUCAGCGACUUAUAUUCUGUAGCAAGGUUAACCGAAUAGGGGAGCCGAAGGGAAACCGAGUCUUAACUGGGCGUUAAGUUGCAGGGUAUAGACCCGAAACCCGGUGAUCUAGCCAUGGGCAGGUUGAAGGUUGGGUAACACUAACUGGAGGACCGAACCGACUAAUGUUGAAAAAUUAGCGGAUGACUUGUGGCUGGGGGUGAAAGGCCAAUCAAACCGGGAGAUAGCUGGUUCUCCCCGAAAGCUAUUUAGGUAGCGCCUCGUGAAUUCAUCUCCGGGGGUAGAGCACUGUUUCGGCAAGGGGGUCACUUACCAACCCGAUGCAAACUGCGAAUACCGGAGAAUGUUAUCACGGGAGACACACGGCGGGUGCUAACGUCCGUCGUGAAGAGGGAAACAACCCAGACCGCCAGCUAAGGUCCCAAAGUCAUGGUUAAGUGGGAAACGAUGUGGGAAGGCCCAGACAGCCAGGAUGUUGGCUUAGAAGCAGCCAUCAUUUAAAGAAAGCGUAAUAGCUCACUGGUCGAGUCGGCCUGCGCGGAAGAUGUAACGGGGCUAAACCAUGCACCGAAGCUGCGGCAGCGACGCUUAUGCGUUGUUGGGUAGGGGAGCGUUCUGUAAGCCUGCGAAGGUGUGCUGUGAGGCAUGCUGGAGGUAUCAGAAGUGCGAAUGCUGACAUAAGUAACGAUAAAGCGGGUGAAAAGCCCGCUCGCCGGAAGACCAAGGGUUCCUGUCCAACGUUAAUCGGGGCAGGGUGAGUCGACCCCUAAGGCGAGGCCGAAAGGCGUAGUCGAUGGGAAACAGGUUAAUAUUCCUGUACUUGGUGUUACUGCGAAGGGGGGACGGAGAAGGCUAUGUUGGCCGGGCGACGGUUGUCCCGGUUUAAGCGUGUAGGCUGGUUUUCCAGGCAAAUCCGGAAAAUCAAGGCUGAGGCGUGAUGACGAGGCACUACGGUGCUGAAGCAACAAAUGCCCUGCUUCCAGGAAAAGCCUCUAAGCAUCAGGUAACAUCAAAUCGUACCCCAAACCGACACAGGUGGUCAGGUAGAGAAUACCAAGGCGCUUGAGAGAACUCGGGUGAAGGAACUAGGCAAAAUGGUGCCGUAACUUCGGGAGAAGGCACGCUGAUAUGUAGGUGAGGUCCCUCGCGGAUGGAGCUGAAAUCAGUCGAAGAUACCAGCUGGCUGCAACUGUUUAUUAAAAACACAGCACUGUGCAAACACGAAAGUGGACGUAUACGGUGUGACGCCUGCCCGGUGCCGGAAGGUUAAUUGAUGGGGUUAGCGCAAGCGAAGCUCUUGAUCGAAGCCCCGGUAAACGGCGGCCGUAACXAUAACGGUCCUAAGGUAGCGAAAUUCCUUGUCGGGUAAGUUCCGACCUGCACGAAUGGCGUAAUGAUGGCCAGGCUGUCUCCACCCGAGACUCAGUGAAAUUGAACUCGCUGUGAAGAUGCAGUGUACCCGCGGCAAGACGGAAAGACCCCGUGAACCUUUACUAUAGCUUGACACUGAACAUUGAGCCUUGAUGUGUAGGAUAGGUGGGAGGCUUUGAAGUGUGGACGCCAGUCUGCAUGGAGCCGACCUUGAAAUACCACCCUUUAAUGUUUGAUGUUCUAACGUUGACCCGUAAUCCGGGUUGCGGACAGUGUCUGGUGGGUAGUUUGACUGGGGCGGUCUCCUCCUAAAGAGUAACGGAGGAGCACGAAGGUUGGCUAAUCCUGGUCGGACAUCAGGAGGUUAGUGCAAUGGCAUAAGCCAGCUUGACUGCGAGCGUGACGGCGCGAGCAGGUGCGAAAGCAGGUCAUAGUGAUCCGGUGGUUCUGAAUGGAAGGGCCAUCGCUCAACGGAUAAAAGGUACUCCGGGGAUAACAGGCUGAUACCGCCCAAGAGUUCAUAUCGACGGCGGUGUUUGGCACCUCGAUGUCGGCUCAUCACAUCCUGGGGCUGAAGUAGGUCCCAAGGGUAUGGCUGUUCGCCAUUUAAAGUGGUACGCGAGCUGGGUUUAGAACGUCGUGAGACAGUUCGGUCCCUAUCUGCCGUGGGCGCUGGAGAACUGAGGGGGGCUGCUCCUAGUACGAGAGGACCGGAGUGGACGCAUCACUGGUGUUCGGGUUGUCAUGCCAAUGGCACUGCCCGGUAGCUAAAUGCGGAAGAGAUAAGUGCUGAAAGCAUCUAAGCACGAAACUUGCCCCGAGAUGAGUUCUCCCUGACCCUUUAAGGGUCCUGAAGGAACGUUGAAGACGACGACGUUGAUAGGCCGGGUGUGUAAGCGCAGCGAUGCGUUGAGCUAACCGGUACUAAUGAACCGUGAGGCUUAACCU	Kitasamycin	Target_lig_1144	50S subunit	Target_100	8.17069622716898
1002	CC1=CC=CN2C1=NC3=C(C2=O)C=C(C(=N)N3CC4=CN=CC=C4)C(=O)NCCN5CCOCC5	AGGACUCGGCUUGCUGAAGCGCGCGACGGCAAGAGGCGAGGGGCGGCGACUGGUGAGUACGCCAAAAAUUUUGACUAGCGGAGGCUAGAAGGAGAGAGAUGGGUGCGAGAGCGUCGGU	SL3 RNA_ligand14	Target_lig_617	SL3 RNA	Target_146	4.48148606012211
1046	O1COc2c1cc(C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)NCCCN)CCCCN)CSSC[C@H](NC(=O)[C@@H]3CCCN3C(=O)c3cc4OCOc4cc3)C(=O)N[C@H](C(=O)NCCCN)CCCCN)CCC1)cc2	CGCGCUGCUGCGCG	ligand 3-3	Target_lig_621	RNA seq D	Target_155	5.1249387366083
399	CCC(C)C1C(=O)NC(C(=O)NC(=C)C(=O)NC(C(=O)NC23CCC(=NC2C4=CSC(=N4)C(C(OC(=O)C5=NC6=C(C=CC(C6O)N1)C(=C5)C(C)O)C)NC(=O)C7=CSC(=N7)C(NC(=O)C8CSC(=N8)C(=CC)NC(=O)C(NC(=O)C9=CSC3=N9)C(C)O)C(C)(C(C)O)O)C1=NC(=CS1)C(=O)NC(=C)C(=O)NC(=C)C(=O)N)C)C	GCUGGGAUGUUGGCUUAGAAGCAGCCAUCAUUUAAAGAGUGCGUAACAGCUCACCAGC	Thiostrepton	Target_lig_319	L11 BD RNA	Target_122	5.88605664769316
697	C1CNCCC1C2=NC3=CC(=C(C=C3N2CC4=CC=CC=C4Br)Cl)Cl	GAGCGUCACACCUUCGGGUGAAGUCGCUC	benzimidazole_analog_rRNA_40	Target_lig_456	16s_rRNA A SITE	Target_3	3.2269453066357405
2376	CCCCOC(=O)C1=CC=C(C=C1)N	UUUUUUAGGGAAGAUCUGGCCUUCCCACAAGGGAAGGCCAGGGAAUUUUCUU	Butamben	Target_lig_1222	HIV-1FRAMESHIFT STEM LOOP STRUCTURE	Target_109	4.40450377817443
133	C1CN(CCN1CC2=CNC3=CC=CC=C32)CC4=CNC5=CC=CC=C54	GAGCGUCACACCUUCGGGUGAAGUCGCUC	1,4-bis((1H-indol-3-yl)methyl)piperazine	Target_lig_104	A-site 16S rRNA_E_coli (1)	Target_3	3.66554624884907
2185	CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CC=C(O3)CN)N)N)N)O	CUGUCUUCACGCAGAAAGCGUCUAGCCAUGGCGUUAGUAUGAGUGUCG	sisomicin	Target_lig_10	HCV IRES Domain Iib	Target_408	5.36653154442041
2215	CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CC=C(O3)CN)N)N)N)O	GGCUGACCAUCAAUAAGGAAGAAGCCCUUCAGCGGCCAGUA	sisomicin	Target_lig_10	HIV protease active site (PAS) mRNA	Target_409	4.82390874094432
2321	CNc1ncc(cn1)CN1CCC[C@H](C1)c1nc(O)cc(n1)c1cccs1	GGCGUGUAGGAUAUGCUUCGGCAGAAGGACACGCC	Ribocil-A	Target_lig_1187	FMN RIBOSWITCH APTAMER	Target_36	5.0
2386	NCCCNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Nc1ccc2c(c1)C(=O)c1c(C2=O)cccc1)CSSC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCCCN)Cc1ccccc1)Nc1ccc2c(c1)C(=O)c1c(C2=O)cccc1	UUUUUUAGGGAAGAUCUGGCCUUCCCACAAGGGAAGGCCAGGGAAUUUUCUU	ethylquinoline_carboxamide derivative 5	Target_lig_1227	HIV-1FRAMESHIFT STEM LOOP STRUCTURE	Target_109	6.6382721639824105
2361	CNC1C(OC2OC(Cn3nnc(c3)CCC(=O)Nc3cccc(c3)c3csc(n3)NC(=O)C)C(C(C2O)O)N)OC2C(C1O)OC(C(C2)N)OC1C(N)CC(C(C1O)O)N	GAGCGUCACACCUUCGGGUGAAGUCGCUC	Apramycin	Target_lig_772	16s_rRNA A SITE	Target_3	5.69897000433602
1005	CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F	AGGACUCGGCUUGCUGAAGCGCGCGACGGCAAGAGGCGAGGGGCGGCGACUGGUGAGUACGCCAAAAAUUUUGACUAGCGGAGGCUAGAAGGAGAGAGAUGGGUGCGAGAGCGUCGGU	SL3 RNA_ligand17	Target_lig_620	SL3 RNA	Target_146	4.04575749056068
39	C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C=C3NC4=CC(=C(C=C4)NC5=NC(=NC(=N5)NC6=CC=CC=C6S(=O)(=O)O)Cl)S(=O)(=O)O)S(=O)(=O)O)N	GGGAGAATTCCCGCGGCAGAAGCCCACCTGGCTTTGAACTCTATGTTATTGGGTGGGGGAAACTTAAGAAAACTACCACCCTTCAACATTACCGCCCTTCAGCCTGCCAGCGCCCTGCAGCCCGGGAAGCTT	Cibacron blue	Target_lig_27	RNA_APTAMER_CB_42	Target_4	4.0
2461	OCC1OC(OC2C(N)CC(C(C2O)OC2OC(CNC(=O)c3ccc(c(c3)C(=O)O)c3c4ccc(=[N+](C)C)cc4oc4c3ccc(c4)N(C)C)C(CC2N)O)N)C(C(C1O)N)O	CCCCCCCGCCGCGCCAUGCCUGUGGCCGGGGGG	CRT	Target_lig_993	TS mRNA Construct_4	Target_445	6.05700040663396
2170	CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CC=C(O3)CN)N)N)N)O	GAAGACAGCCGCUUCUACGAGCAU	sisomicin	Target_lig_10	E. coli transglycosidase mRNA	Target_407	4.92081875395238
1038	O1COc2c1cc(C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)NCCCN)CCCCN)CSSC[C@H](NC(=O)[C@@H]3CCCN3C(=O)c3cc4OCOc4cc3)C(=O)N[C@H](C(=O)NCCCN)CCCCN)CCC1)cc2	GGGCUGCUGCUGCUGCUGGGG	ligand 3-3	Target_lig_621	RNA seq B	Target_153	5.602059991327961
1015	CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F	AUCACCUCCUUAUAAGGAGGUGAU	SL3 RNA_ligand17	Target_lig_620	Double stranded RNA seq	Target_149	2.95506845385084
1280	[NH3+]CCS(=O)(=O)C[C@H]([NH3+])C([O-])=O	GAAGAUAGAGGUGCGAACUUCAAGAGUAUGCCUUUGGAGAAAGAUGGAUUCUGUGAAAAAGGCUGAAAGGGGAGCGUCGCCGAAGCAAAUAAAACCCCAUCGGUAUUAUUUGCUGGCCGUGCAUUGAAUAAAUAUAAGGCUGUCAAGAAAUCAUUUUCUUGGAGGGCUAUCUCGUUGUUCAUAAUCAUUUAUGAUGAUUAAUUGAUAAGCAAUGAGAGUAUUCCUCUCAUUGCUUUUUU	Lysine Analog 8	Target_lig_1260	lysC riboswitch	Target_229	5.602059991327961
1282	[NH3+]CCS(=O)(=O)C[C@H]([NH3+])C([O-])=O	GAAGAUAGAGGUGCGAACUUCAAGAGUAUGCCUUUGGAGAAAGAUGGAUUCUGUGAAAAAGGCUGAAGGGGAGCGUCGCCGAAGCAAAUAAAACCCCAUCGGUAUUAUUUGCUGGCCGUGCAUUGAAUAAAUGUAAGGCUGUCAAGAAAUCAUUUUCUUGGAGGGCUAUCUCGUUGUUCAUAAUCAUUUAUGAUGAUUAAUUGAUAAGCAAUGAGAGUAUUCCUCUCAUUGCUUUUUU	Lysine Analog 8	Target_lig_1260	lysC riboswitch mutant 1 (M2)	Target_230	4.619788758288389
1062	CCCN(CC(=O)N(CCC)CC(=O)N(CC(N)=O)CC1=CN(CCCNC(=O)CCCOC2=C(C=C(C=C2C(C)(C)C)C2=NC3=CC(=CC=C3N2)N2CC[NH+](C)CC2)C(C)(C)C)N=N1)C(=O)CCCOC1=CC=CC(=C1)C1=NC2=CC(=CC=C2N1)C1=NC2=CC(=CC=C2N1)N1CC[NH+](C)CC1	GGGAGAGGGUUUACGAACGAAAGUUGGUGGAUCCGCAAGG	Targaprimir-96	Target_lig_627	Pri-miR-96 RNA2 (desired GG loop only)	Target_161	6.045757490560679
1819	CN(c1nc(N)c(nc1c1ccc(cc1)c1ccccc1)C(=O)NC(=[NH2+])N)C	GGAUCAAUAGCAGGUGUGGCACACCAGUCAUACCUUGAUCC	DMA-155	Target_lig_1021	EV71 SLII RNA	Target_329	6.251811972993799
